Results 71 to 80 of about 294 (89)

Mitochondrial dysfunction: A promising therapeutic target for liver diseases. [PDF]

open access: yesGenes Dis
Chen P   +6 more
europepmc   +1 more source

Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis

open access: yesJournal of Microencapsulation, 1989
The preparation and physico-chemical characterization of lyophilized polyisohexylcyanoacrylate nanoparticles loaded with dehydroemetine (DHE) for the treatment of visceral leishmaniasis disease is described.
Patrick Couvreur, M Roland
exaly   +2 more sources

Dehydroemetine in Amebic Dysentery and Amebic Liver Abscess

open access: yesAmerican Journal of Tropical Medicine and Hygiene, 1962
S J Powell, A J Wilmot, R Elsdon-Dew
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Observations on the hypotensive response to dehydroemetine

European Journal of Pharmacology, 1971
L A Salako
exaly  

Responses of skeletal muscle to dehydroemetine

European Journal of Pharmacology, 1970
L A Salako
exaly  

Effects of emetine and dehydroemetine at the frog neuromuscular junction

European Journal of Pharmacology, 1987
Karim A Alkadhi
exaly  

Home - About - Disclaimer - Privacy